Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youwei Bi

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of Biopharmaceutical Statistics|December 8, 2022
How to select the initial dose for a pediatric study?Jingjing Ye, Youwei Bi, Naitee Ting
The AAPS Journal|November 13, 2015
A Whole-Body Physiologically Based Pharmacokinetic Model of Gefitinib in Mice and Scale-Up to HumansYouwei Bi, Jiexin Deng, Daryl J Murry, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 14, 2018
Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male SubjectsYouwei Bi, Paul J Perry, Michael Ellerby, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 3, 2012
β-Cyclodextrin enhanced on-line organic solvent field-amplified sample stacking in capillary zone electrophoresis for analysis of ambroxol in human plasma, following liquid-liquid extraction in the 96-well formatJi Li, Youwei Bi, Li Wang, et al.
Clinical Pharmacology and Therapeutics|May 2, 2024
Approval of Mycophenolate Mofetil for Prophylaxis of Organ Rejection in Pediatric Recipients of Heart or Liver Transplants: A Regulatory PerspectiveAmer Al-Khouja, Nadia Chaudhri, Ergun Velidedeoglu, et al.
Annals of the American Thoracic Society|April 8, 2017
Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary FibrosisMiya O Paterniti, Youwei Bi, Dinko Rekić, et al.
Journal of Clinical Pharmacology|September 27, 2025
Approval of Upadacitinib in Pediatric Patients with Active Polyarticular Juvenile Idiopathic Arthritis or Active Psoriatic Arthritis: A Regulatory PerspectiveLei He, Da Zhang, Eric J Gapud, et al.
The AAPS Journal|July 21, 2019
Model-Informed Drug Development Approach Supporting Approval of Adalimumab (HUMIRA) in Adolescent Patients with Hidradenitis Suppurativa: a Regulatory PerspectiveYouwei Bi, Jiang Liu, Jie Wang, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 19, 2020
A disease progression model of longitudinal lung function decline in idiopathic pulmonary fibrosis patientsYouwei Bi, Dinko Rekić, Miya O Paterniti, et al.
Journal of Clinical Pharmacology|November 9, 2023
Model-Informed Approaches to Support Drug Development for Patients With Obesity: A Regulatory PerspectiveXiaolei Pan, Li Wang, Jiang Liu, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of Biopharmaceutical Statistics|December 8, 2022
How to select the initial dose for a pediatric study?Jingjing Ye, Youwei Bi, Naitee Ting
The AAPS Journal|November 13, 2015
A Whole-Body Physiologically Based Pharmacokinetic Model of Gefitinib in Mice and Scale-Up to HumansYouwei Bi, Jiexin Deng, Daryl J Murry, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 14, 2018
Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male SubjectsYouwei Bi, Paul J Perry, Michael Ellerby, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 3, 2012
β-Cyclodextrin enhanced on-line organic solvent field-amplified sample stacking in capillary zone electrophoresis for analysis of ambroxol in human plasma, following liquid-liquid extraction in the 96-well formatJi Li, Youwei Bi, Li Wang, et al.
Clinical Pharmacology and Therapeutics|May 2, 2024
Approval of Mycophenolate Mofetil for Prophylaxis of Organ Rejection in Pediatric Recipients of Heart or Liver Transplants: A Regulatory PerspectiveAmer Al-Khouja, Nadia Chaudhri, Ergun Velidedeoglu, et al.
Annals of the American Thoracic Society|April 8, 2017
Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary FibrosisMiya O Paterniti, Youwei Bi, Dinko Rekić, et al.
Journal of Clinical Pharmacology|September 27, 2025
Approval of Upadacitinib in Pediatric Patients with Active Polyarticular Juvenile Idiopathic Arthritis or Active Psoriatic Arthritis: A Regulatory PerspectiveLei He, Da Zhang, Eric J Gapud, et al.
The AAPS Journal|July 21, 2019
Model-Informed Drug Development Approach Supporting Approval of Adalimumab (HUMIRA) in Adolescent Patients with Hidradenitis Suppurativa: a Regulatory PerspectiveYouwei Bi, Jiang Liu, Jie Wang, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 19, 2020
A disease progression model of longitudinal lung function decline in idiopathic pulmonary fibrosis patientsYouwei Bi, Dinko Rekić, Miya O Paterniti, et al.
Journal of Clinical Pharmacology|November 9, 2023
Model-Informed Approaches to Support Drug Development for Patients With Obesity: A Regulatory PerspectiveXiaolei Pan, Li Wang, Jiang Liu, et al.
Pageof 4